Evidence map›Paper›PMID 27668660›Full record

ArticleNature genetics2016

An inducible long noncoding RNA amplifies DNA damage signaling.

Adam M Schmitt, Julia T Garcia, Tiffany Hung, Ryan A Flynn, Ying Shen, Kun Qu, Alexander Y Payumo, Ashwin Peres-da-Silva, Daniela Kenzelmann Broz, Rachel Baum and 4 more

Abstract read
In one paragraph

Article in Nature genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 161 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 3 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 3 syntheses or guidelines pooled it, 234 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. IncRNA-ZFAS1, an Emerging Gate-Keeper in DNA Damage-Dependent Transcriptional Regulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  19. Review
  20. Article

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Adam M SchmittCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Julia T GarciaCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Tiffany HungCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Ryan A FlynnCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Ying ShenCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Kun QuCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Alexander Y PayumoDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California, USA.
Ashwin Peres-da-SilvaCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Daniela Kenzelmann BrozDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Rachel BaumDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Shuling GuoDepartment of Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, California, USA.
James K ChenDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California, USA.
Laura D AttardiDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
Howard Y ChangCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USIonis Pharmaceuticals (United States) · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
INSTITUTIONAL TRAINING GRANT IN GENOME SCIENCET32HG000044 · NHGRI · STANFORD UNIVERSITY · PI MICHAEL P. SNYDER · 1995 to 2026
$32.2M
UCSF IRACDA Scholars ProgramK12GM081266 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Raymond M. Esquerra, HOLLY A. INGRAHAM · 2007 to 2026
$19.4M
Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
TRAINING & OUTREACH COREP50GM107615 · NIGMS · STANFORD UNIVERSITY · PI COVERT, MARKUS W · 2013 to 2017
$10.9M
Structural Motifs in RNAR01HG004361 · NHGRI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2007 to 2018
$4.7M
Wound Response Genes in Cancer ProgressionR01CA118750 · NCI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2007 to 2016
$2.9M
LncRNA regulation of environmental responseR01ES023168 · NIEHS · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2013 to 2016
$2.2M
Chemical Embryology: Technologies for Manipulating and Visualizing DevelopmentDP1HD075622 · NICHD · STANFORD UNIVERSITY · PI CHEN, JAMES K · 2012 to 2012
$792k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA124435NCI NIH HHS R01 CA118750NCI NIH HHS T32 CA009302NHGRI NIH HHS R01 HG004361NHGRI NIH HHS T32 HG000044NICHD NIH HHS DP1 HD075622NIEHS NIH HHS R01 ES023168NIGMS NIH HHS K12 GM081266NIGMS NIH HHS P50 GM107615
6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) are prevalent genes with frequently precise regulation but mostly unknown functions. Here we demonstrate that lncRNAs guide the organismal DNA damage response. DNA damage activated transcription of the DINO (Damage Induced Noncoding) lncRNA via p53. DINO was required for p53-dependent gene expression, cell cycle arrest and apoptosis in response to DNA damage, and DINO expression was sufficient to activate damage signaling and cell cycle arrest in the absence of DNA damage. DINO bound to p53 protein and promoted its stabilization, mediating a p53 auto-amplification loop. Dino knockout or promoter inactivation in mice dampened p53 signaling and ameliorated acute radiation syndrome in vivo. Thus, inducible lncRNA can create a feedback loop with its cognate transcription factor to amplify cellular signaling networks.

Indexed as

DNA DamageAnimalsCell LineFeedback, PhysiologicalFemaleHumansMaleMice, Inbred C57BLMice, KnockoutRatsRNA, Long NoncodingSignal TransductionTumor Suppressor Protein p53DINOL lncRNA, humanRNA, Long NoncodingTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID27668660
PMCPMC5083181
OpenAlexW2525843044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.